Home

Jim L. Allen

CIK 1789590 · last filed 2026-07-07

Jim L. Allen is a corporate insider who has filed 16 SEC Form 4 insider transactions across 2 companies since 2020. The most recent filing, for BCDA, was dated Jul 7, 2026. Across all open-market trades the lifetime net is +$300.0K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $85.7K across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$85.7K

Companies

2

Total Filings

16

Lifetime Open-Market Net

$300.0K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
BCDA Director 109,667 $0.78 $85.7K $0 4 2026-07-07
BioCardia, Inc. (BCDAW) Delisted Director 894,835 $0.01 $5.5K $300.0K 12 2023-10-19

Recent Filings

16 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-07-07 BCDA Grant (A) — $0 EDGAR
2025-12-10 BCDA Grant (A) — $0 EDGAR
2024-10-16 BCDA Grant (A) — $0 EDGAR
2024-09-05 BCDA Grant (A) +50,000 $150.0K EDGAR
2023-10-19 BioCardia, Inc. (BCDAW) Delisted Grant (A) — $0 EDGAR
2023-06-26 BioCardia, Inc. (BCDAW) Delisted Grant (A) +64,212 $150.0K EDGAR
2022-12-19 BioCardia, Inc. (BCDAW) Delisted Grant (A) +148,809 $250.0K EDGAR
2022-09-30 BioCardia, Inc. (BCDAW) Delisted Grant (A) — $0 EDGAR
2021-06-15 BioCardia, Inc. (BCDAW) Delisted Grant (A) — $0 EDGAR
2021-04-07 BioCardia, Inc. (BCDAW) Delisted Grant (A) +2,520 $0 EDGAR
Showing 1–10 of 16
Page 1 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.